Mark Radlinski

517 total citations · 1 hit paper
12 papers, 360 citations indexed

About

Mark Radlinski is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Mark Radlinski has authored 12 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Gastroenterology. Recurrent topics in Mark Radlinski's work include Esophageal and GI Pathology (6 papers), Gallbladder and Bile Duct Disorders (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Mark Radlinski is often cited by papers focused on Esophageal and GI Pathology (6 papers), Gallbladder and Bile Duct Disorders (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Mark Radlinski collaborates with scholars based in United States, United Kingdom and Canada. Mark Radlinski's co-authors include Michelle Lee, Daniel J. Antoine, Sahil Sharma, James W. Dear, Rebecca A. Betensky, Joseph V. Bonventre, Venkata Sabbisetti, Sushrut S. Waikar, Andrzej S. Królewski and Philip L. De Jager and has published in prestigious journals such as Gastroenterology, Journal of the American Society of Nephrology and The American Journal of Gastroenterology.

In The Last Decade

Mark Radlinski

8 papers receiving 354 citations

Hit Papers

Blood Kidney Injury Molecule-1 Is a Biomarker of Acute an... 2014 2026 2018 2022 2014 100 200 300

Peers

Mark Radlinski
Rebeccah Briskin United States
Mark Radlinski
Citations per year, relative to Mark Radlinski Mark Radlinski (= 1×) peers Rebeccah Briskin

Countries citing papers authored by Mark Radlinski

Since Specialization
Citations

This map shows the geographic impact of Mark Radlinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Radlinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Radlinski more than expected).

Fields of papers citing papers by Mark Radlinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Radlinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Radlinski. The network helps show where Mark Radlinski may publish in the future.

Co-authorship network of co-authors of Mark Radlinski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Radlinski. A scholar is included among the top collaborators of Mark Radlinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Radlinski. Mark Radlinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Saeed, Aamir, Janak N. Shah, Mark Radlinski, et al.. (2025). Efficacy of fully covered self-expandable metal stents and comparison with conventional management for ERCP-related type II perforations: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 102(5). 738–742.e2. 2 indexed citations
3.
Saeed, Aamir, Manesh Kumar Gangwani, Muhammad Aziz, et al.. (2024). Efficacy and safety of fully covered self-expandable metal stents in the management of postsphincterotomy bleeding: systematic review and meta-analysis. Gastrointestinal Endoscopy. 101(6). 1110–1117.e3.
4.
Radlinski, Mark, Daniel S. Strand, Bryan G. Sauer, et al.. (2023). Socioeconomic Disparities Affect Outcomes in Early-Stage Esophageal Adenocarcinoma: A SEER Analysis. Clinical Gastroenterology and Hepatology. 21(11). 2797–2806.e6. 9 indexed citations
5.
Radlinski, Mark, et al.. (2022). 261: EUS-GUIDED PORTAL PRESSURE MEASUREMENTS – A SINGLE CENTER RETROSPECTIVE CASE SERIES. Gastroenterology. 162(7). S–57. 1 indexed citations
6.
Radlinski, Mark, Daniel S. Strand, & Vanessa M. Shami. (2022). Evolution of interventional endoscopic ultrasound. Gastroenterology report. 11. goad038–goad038. 9 indexed citations
7.
Radlinski, Mark & Vanessa M. Shami. (2022). Role of endoscopic ultrasound in esophageal cancer. World Journal of Gastrointestinal Endoscopy. 14(4). 205–214. 6 indexed citations
8.
Radlinski, Mark, et al.. (2022). S3460 Olmesartan-Induced Enteropathy With Associated Anti-Enterocyte Antibody. The American Journal of Gastroenterology. 117(10S). e2180–e2180.
10.
Radlinski, Mark, Linda W. Martin, Dustin M. Walters, et al.. (2020). Use of endoscopic ultrasound in pre-treatment staging of esophageal cancer did not alter management plan. Journal of Thoracic Disease. 12(10). 5850–5856. 5 indexed citations
11.
Radlinski, Mark, et al.. (2020). Post-Treatment Ulceration and Bleeding After Cyanoacrylate Injection of Duodenal Varices. ACG Case Reports Journal. 7(3). e00342–e00342.
12.
Sabbisetti, Venkata, Sushrut S. Waikar, Daniel J. Antoine, et al.. (2014). Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes. Journal of the American Society of Nephrology. 25(10). 2177–2186. 327 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026